Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro...
Transcript of Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro...
![Page 1: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de](https://reader034.fdocuments.net/reader034/viewer/2022043004/5f875efd20ab414d5549357a/html5/thumbnails/1.jpg)
Complex in vitro models to study oral application and exposure
Berlin, 8. Mai [email protected] Institute for Pharmaceutical Research SaarlandDepartment of Drug Delivery (DDEL)
![Page 2: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de](https://reader034.fdocuments.net/reader034/viewer/2022043004/5f875efd20ab414d5549357a/html5/thumbnails/2.jpg)
Inflammatory bowel disease
A group chronic or recurrent inflammatory conditions of the colon and small intestine (Crohn’s Disease and Ulcerative Colitis)
Symptoms: diarrhea, weight loss, pain
Treatment: induction and maintenance ofremission using immunosuppresents, glucocorticoids, monoclonal antibodies(anti TNF-α)
Page 2 |
![Page 3: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de](https://reader034.fdocuments.net/reader034/viewer/2022043004/5f875efd20ab414d5549357a/html5/thumbnails/3.jpg)
State of the art: animal models in drug/formulation development for IBD treatment
Rodent colitis models-Transgenic- Chemically induced, e.g. TNBS, DSS
Arita M et al. PNAS 2005;102:7671-7676
Symptoms:Diarrhea, rectal bleeding, weight loss, pain, colon perforation, sepsis, death
Evaluation of treatment: scoring system, histological stainings, weight and length of colon
Issues: unethical, differences in species and pathogenesis
Page 3 |
![Page 4: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de](https://reader034.fdocuments.net/reader034/viewer/2022043004/5f875efd20ab414d5549357a/html5/thumbnails/4.jpg)
The work horse: the Caco-2 model
Caco-2 monolayer Intestinal mucosa
Page 4 |
![Page 5: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de](https://reader034.fdocuments.net/reader034/viewer/2022043004/5f875efd20ab414d5549357a/html5/thumbnails/5.jpg)
Adding complexity: immune cells
Page 5 |
![Page 6: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de](https://reader034.fdocuments.net/reader034/viewer/2022043004/5f875efd20ab414d5549357a/html5/thumbnails/6.jpg)
In vitro model of the inflamed intestinal mucosa
Page 6 |
Co-culture of Caco-2 intestinal epithelial cells with blood derived dendritriccells and macrophages
Stimulation of inflammation by addition of lipopolysaccharides orpro-inflammatory cytokines (interleukin-1β) to the cell culture medium
Reflects the relevant pathophysiological changes occuring in vivo
![Page 7: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de](https://reader034.fdocuments.net/reader034/viewer/2022043004/5f875efd20ab414d5549357a/html5/thumbnails/7.jpg)
In vitro model of the inflamed intestinal mucosa
Page 7 |
Collagen layer
Filter membrane
![Page 8: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de](https://reader034.fdocuments.net/reader034/viewer/2022043004/5f875efd20ab414d5549357a/html5/thumbnails/8.jpg)
In vitro model of the inflamed intestinal mucosa:release of pro-inflammatory marker IL-8
Page 8 |
Leonard et al, Mol Pharm: 7, 2103 – 2119, 2010
![Page 9: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de](https://reader034.fdocuments.net/reader034/viewer/2022043004/5f875efd20ab414d5549357a/html5/thumbnails/9.jpg)
Tight junction protein ZO-1control
inflamed
IL-1ß stimulation
In vitro model of the inflamed intestinal mucosa:changes in barrier properties
Page 9 |
Leonard et al, Mol Pharm: 7, 2103 – 2119, 2010
![Page 10: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de](https://reader034.fdocuments.net/reader034/viewer/2022043004/5f875efd20ab414d5549357a/html5/thumbnails/10.jpg)
Pathophysiological changes in the inflamed mucosa:Threat or potential?
Healthy mucosal barrier Inflamed mucosal barrier
Macrophage
Intestinal epithelial cell
Tight junctions
MicroparticleNanoparticle
Page 10 |
Collnot et al, J Control Release 2012, in press
![Page 11: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de](https://reader034.fdocuments.net/reader034/viewer/2022043004/5f875efd20ab414d5549357a/html5/thumbnails/11.jpg)
Budesonide formulations for the treatment of IBD
Budesonide PLGA nanoparticles Liposomal budesonide
size ~220 nm, PDI: 0.08 size ~ 200 nm, PDI: 0.05 encapsulation rate: 67 µg/mg encapsulation rate: 4.2 mg/mlencapsulation efficiency: 46% encapsualtion efficiency: 4.2%
Diluted or suspended in Caco-2 medium to a concentration of 100 µg/ml
Page 11 |
![Page 12: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de](https://reader034.fdocuments.net/reader034/viewer/2022043004/5f875efd20ab414d5549357a/html5/thumbnails/12.jpg)
Testing of anti-inflammatory formulations in the inflamed 3D model
Page 12 |
Leonard et al, ALTEX, accepted
![Page 13: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de](https://reader034.fdocuments.net/reader034/viewer/2022043004/5f875efd20ab414d5549357a/html5/thumbnails/13.jpg)
Testing of anti-inflammatory formulations in the inflamed 3D model
Budesonide PLGA nanoparticles
Liposomal budesonide
Leonard et al, ALTEX, acceptedPage 13 |
![Page 14: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de](https://reader034.fdocuments.net/reader034/viewer/2022043004/5f875efd20ab414d5549357a/html5/thumbnails/14.jpg)
Toxicity testing of engineered nanoparticles: InLiveTox
Page 14 |
![Page 15: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de](https://reader034.fdocuments.net/reader034/viewer/2022043004/5f875efd20ab414d5549357a/html5/thumbnails/15.jpg)
Toxicity testing of engineered nanoparticles: the candidates
NP Nominal Water Completemedium
Ag, PVP capped, NM300
< 20 nm 150 nm 120 nm
TiO2NM 101
7-10 nm >1000 nm 800 nm
Au,Phosphine capped
15 nm 20 nm 51 nm
Au, Phosphine capped
80 nm 88 nm 116 nm
Polystyrene 55 nm 60 nm 55 nm
Polystyrene 211 nm 230 nm 550 nm
Page 15 |
![Page 16: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de](https://reader034.fdocuments.net/reader034/viewer/2022043004/5f875efd20ab414d5549357a/html5/thumbnails/16.jpg)
Toxicity testing in the co-culture model: LDH release
Ag NP concentration [µg/cm2]
1 10 100 1000
Cyt
otox
icty
[%]
-20
0
20
40
60
80
100
120
140
Caco-2 monoculture EC50 = 82 µ/cm²not inflamed triple culture EC50 = 364 µg/cm²inflamed triple culture EC50 = 216 µg/cm²
Page 16 |
![Page 17: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de](https://reader034.fdocuments.net/reader034/viewer/2022043004/5f875efd20ab414d5549357a/html5/thumbnails/17.jpg)
What‘s the reason for the differences observed?
Relative cell numbers in the mature 3D culture:
~106 Caco-2 cells vs. 104 immune cells
LDH leakage and drop in metabolic activity is mainly associated with the Caco-2 cells
Reduced exposure of epithelial cells in the presence of immune cells due to preferential uptake by dendritic cells and macrophages?
Page 17 |
![Page 18: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de](https://reader034.fdocuments.net/reader034/viewer/2022043004/5f875efd20ab414d5549357a/html5/thumbnails/18.jpg)
Toxicity testing in the co-culture model: IL-8 production
Ag NP concentration [µg/cm2]
1,25 2,5 5 9,7719,53
39,06578,125
156,25312,5 625
IL8
rele
ase
[pg/
ml]
0
200
400
600
800
1000
1200
1400
Baseline non-inflamedBaseline inflamed
Baseline Caco-2
Caco-2non-inflamed triple cultureinflamed triple culture
Page 18 |
![Page 19: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de](https://reader034.fdocuments.net/reader034/viewer/2022043004/5f875efd20ab414d5549357a/html5/thumbnails/19.jpg)
Toxicity testing in the co-culture model
Filtrer membrane
Caco-2 cellsNanoparticles
Page 19 |
![Page 20: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de](https://reader034.fdocuments.net/reader034/viewer/2022043004/5f875efd20ab414d5549357a/html5/thumbnails/20.jpg)
Toxicity testing in the co-culture model
Dendritic cells
Macrophages
Collagen layer
Filter membrane
Nanoparticles
Caco-2 cells
Protective function of the immune cells in the 3D culture:• preferential uptake of NM300 Ag NP• reduced exposure of epithelial cells• induction of immune answer in response to xenobiotic threats
Page 20 |
![Page 21: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de](https://reader034.fdocuments.net/reader034/viewer/2022043004/5f875efd20ab414d5549357a/html5/thumbnails/21.jpg)
Toxicity testing of engineered nanoparticles: InLiveTox
Page 21 |
![Page 22: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de](https://reader034.fdocuments.net/reader034/viewer/2022043004/5f875efd20ab414d5549357a/html5/thumbnails/22.jpg)
Dynamic cell culture and interconnected systems: InLiveTox
Page 22 |
![Page 23: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de](https://reader034.fdocuments.net/reader034/viewer/2022043004/5f875efd20ab414d5549357a/html5/thumbnails/23.jpg)
The next generation: The InLiveTox system-Interconnected culture and systemic uptake-
Page 23
ILT2: Caco-2ILT0: HUVEC
ILT0: C3A
Lower circuit, medium reservoirUpper circuit, medium reservoir
Bubble trap
![Page 24: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de](https://reader034.fdocuments.net/reader034/viewer/2022043004/5f875efd20ab414d5549357a/html5/thumbnails/24.jpg)
It‘s all about support: silica membranes
0,5 µm10 µm
Page 24 |
![Page 25: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de](https://reader034.fdocuments.net/reader034/viewer/2022043004/5f875efd20ab414d5549357a/html5/thumbnails/25.jpg)
It‘s all about support: silica membranes
Caco-2
Page 25 |
ZO-1
![Page 26: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de](https://reader034.fdocuments.net/reader034/viewer/2022043004/5f875efd20ab414d5549357a/html5/thumbnails/26.jpg)
It‘s all about support: improved transport properties
Page 26 |
1 µm CSEM
2 µm CSEM
3 µm CSEM
0,4 µm BD
1 µm BD
3 µm BD
0,4 µm Corning
3 µm Corning
Nan
opar
ticle
s am
ount
in b
asol
ater
al c
ompa
rtmen
t nor
mal
ized
with
initi
al a
mou
nt a
nd c
ompa
rtmen
t rat
io
0,0
0,2
0,4
0,6
0,8
1,0
1,2
1,4
1 h 4 h 24 h
1µm 2µm 3µm 0.4µm 1µm 3µm 0.4µm 3µm
Silicon nitride BD membrane Corningmembrane membrane
![Page 27: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de](https://reader034.fdocuments.net/reader034/viewer/2022043004/5f875efd20ab414d5549357a/html5/thumbnails/27.jpg)
It‘s all about support: automated TEER measurements
Page 27 |
![Page 28: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de](https://reader034.fdocuments.net/reader034/viewer/2022043004/5f875efd20ab414d5549357a/html5/thumbnails/28.jpg)
Summary
New tools for pharmakokinetic/toxikokinetic and mechanistic in vitro studies
3D co-culture model of the non-inflamed and inflamed intestinal mucosa
Modular two flow system with automated TEER measurements
Silica nitride based membranes with good cell growth properties and improved transport behaviour for macromolecules and nanoparticles
Page 28 |
![Page 29: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de](https://reader034.fdocuments.net/reader034/viewer/2022043004/5f875efd20ab414d5549357a/html5/thumbnails/29.jpg)
Acknowledgements
• HIPS/Saarland UniversityFransisca LeonardJulia SusewindNadia UcciferriClaus-Michael Lehr
• Utrecht UniversityBart CrielaardTwan LammersGert Storm
• Centre Suisse d’Electronique et de MicrotechniqueSher AhmedMelanie FavreSilvia AngeloniMartha Liley
• University of Pisa, Department of engineeringTommaso SbranaArti Ahluwalia
Page 29 |
Thank you for your attention!